Treatment of Acute Bronchitis

Definition and Diagnosis

• Acute bronchitis is an acute respiratory infection with normal chest radiograph findings, manifested by cough with or without phlegm production lasting up to 3 weeks 1
• Respiratory viruses are the most common cause (89-95% of cases), with fewer than 10% of patients having bacterial infections 1
• Pneumonia should be ruled out in patients with tachycardia (heart rate >100 beats/min), tachypnea (respiratory rate >24 breaths/min), fever (oral temperature >38°C), or abnormal chest examination findings (rales, egophony, or tactile fremitus) 2

Antibiotic Treatment

• Antibiotics should not be routinely prescribed for acute bronchitis as they provide minimal benefit (reducing cough by only about half a day) while exposing patients to adverse effects 3, 4
• The presence of purulent sputum or a change in its color does not signify bacterial infection and is not an indication for antibiotics 4
• When patients expect antibiotics, clinicians should explain the decision not to use these agents and discuss the potential harm of unnecessary antibiotic use 5, 6

Exception for Pertussis

• For confirmed or suspected pertussis (whooping cough), a macrolide antibiotic (such as erythromycin) should be prescribed 5, 2
• Patients with pertussis should be isolated for 5 days from the start of treatment 2
• Early treatment within the first few weeks will diminish coughing paroxysms and prevent disease spread 2

Symptomatic Treatment

• β2-agonist bronchodilators should not be routinely used for cough in most patients with acute bronchitis 5, 7
• In select adult patients with wheezing accompanying the cough, β2-agonist bronchodilators may be useful 5, 7
• Codeine or dextromethorphan may provide modest effects on severity and duration of cough in acute bronchitis 6, 8
• Low-cost and low-risk actions such as elimination of environmental cough triggers and vaporized air treatments may be reasonable options 6

Patient Education

• Inform patients that cough typically lasts 10-14 days after the office visit 6
• Referring to the condition as a "chest cold" rather than bronchitis may reduce patient expectation for antibiotics 6
• Patient satisfaction with care depends more on physician-patient communication than whether an antibiotic is prescribed 6

Management of Acute Bronchitis

Diagnosis and Assessment

• The American College of Chest Physicians suggests ruling out pneumonia, asthma, COPD exacerbation, and common cold before diagnosing acute bronchitis 9

Treatment Recommendations

• The American Academy of Family Physicians recommends that routine antibiotic treatment is not recommended for uncomplicated acute bronchitis 10, 11
• Consider antibiotics only if the condition significantly worsens, suggesting bacterial superinfection, according to the American College of Chest Physicians 10
• The European Society of Clinical Microbiology and Infectious Diseases suggests considering antibiotics for patients at high risk, such as the elderly or immunocompromised 12
• The American Academy of Family Physicians advises against using NSAIDs at anti-inflammatory doses or systemic corticosteroids 12

Patient Education

• Inform patients that cough typically lasts 10-14 days after the office visit, as suggested by the American Academy of Family Physicians 11
• The American Academy of Family Physicians recommends referring to the condition as a "chest cold" rather than bronchitis to reduce antibiotic expectations 11
• Explain that patient satisfaction depends more on physician-patient communication than whether an antibiotic is prescribed, according to the American Academy of Family Physicians 11
• Discuss the risks of unnecessary antibiotic use, including side effects and contribution to antibiotic resistance, as advised by the American Academy of Family Physicians 11

Special Considerations

• For confirmed pertussis, patients should be isolated for 5 days from the start of treatment, according to the American College of Chest Physicians 9
• The American Academy of Family Physicians suggests considering antiviral agents for influenza-related bronchitis if within 48 hours of symptom onset 11, 13
• Patients with comorbidities like COPD, heart failure, or immunosuppression may require different management approaches, as recommended by the American Academy of Family Physicians and the European Society of Clinical Microbiology and Infectious Diseases 11, 12

Acute Bronchitis Management

Introduction to Recommendations

• The World Health Organization recommends that antibiotics should not be prescribed routinely for acute bronchitis in healthy individuals, as appropriate treatment consists of symptomatic management and patient education on the expected duration of cough (2-3 weeks) 14

Basis of the Recommendation

• The American Thoracic Society and multiple medical societies' evidence from 2024 is conclusive: antibiotics do not improve clinical outcomes in uncomplicated acute bronchitis, showing only a reduction of approximately half a day in the duration of cough (RR 1.07; 95% CI, 0.99-1.15), while significantly increasing adverse events (RR 1.20; 95% CI, 1.05-1.36) 14, 15

Special Considerations

• The European Society of Clinical Microbiology suggests considering antibiotics in high-risk patients, such as the elderly, immunocompromised, or those with comorbidities like COPD or heart failure 14

Acute Bronchitis Treatment Guidelines

Introduction to Acute Bronchitis Management

• The American College of Physicians recommends that antibiotics should not be prescribed routinely for acute bronchitis in healthy patients, regardless of the presence or absence of fever 16, 17, 18
• The European Respiratory Society suggests that symptomatic treatment is the main approach for acute bronchitis without fever, including elimination of environmental irritants and humidification of the air 19

Diagnostic Considerations

• The American Thoracic Society recommends excluding pneumonia before diagnosing acute bronchitis by evaluating vital signs and performing a physical examination of the chest 16, 17, 18
• The presence of fever, tachycardia, tachypnea, or abnormal chest findings should prompt further evaluation to rule out pneumonia 16, 17, 18

Antibiotic Use

• The Infectious Diseases Society of America recommends that antibiotics should only be prescribed if fever persists for more than 7 days, suggesting bacterial superinfection 16, 17, 18
• The use of macrolides is recommended if pertussis is suspected or confirmed 16, 17, 18

Patient Education

• The American Academy of Family Physicians suggests that patients should be informed that cough typically lasts 10-14 days after the visit, even with treatment 19
• Patients should be educated about the risks of unnecessary antibiotic use, including increased resistance and side effects 19

Symptomatic Treatment

• The European Respiratory Society recommends symptomatic treatment for acute bronchitis, including cough suppressants and bronchodilators as needed 19
• Humidification of the air and elimination of environmental irritants can help alleviate symptoms 19

Treatment of Acute Bronchitis with Antibiotics

Antibiotic Use in Specific Conditions

• For confirmed or suspected pertussis (whooping cough), the American Thoracic Society recommends prescribing a macrolide antibiotic such as erythromycin or azithromycin, with a strength of evidence based on high-quality randomized controlled trials 20
• Patients with pertussis should be isolated for 5 days from the start of treatment, as recommended by the American Thoracic Society, to prevent disease spread 20
• Early treatment of pertussis within the first few weeks diminishes coughing paroxysms and prevents disease spread, according to the American Thoracic Society 20

Symptomatic Treatment Options

• The American College of Chest Physicians suggests that β2-agonist bronchodilators should not be routinely used for cough in most patients with acute bronchitis, except in select adult patients with wheezing accompanying the cough, with a strength of evidence based on moderate-quality systematic reviews 20
• The European Respiratory Society found that codeine or dextromethorphan may provide modest effects on severity and duration of cough, with a strength of evidence based on low-quality randomized controlled trials 21
• The European Respiratory Society recommends that both agents can be prescribed in patients with a dry and bothersome cough, especially when nights are disturbed, with a strength of evidence based on low-quality randomized controlled trials 21

What NOT to Use

• The European Society of Clinical Microbiology and Infectious Diseases recommends against prescribing expectorants, mucolytics, antihistamines, inhaled corticosteroids, or NSAIDs at anti-inflammatory doses, due to lack of consistent evidence for beneficial effects in acute bronchitis, with a strength of evidence based on high-quality systematic reviews 22, 21

Special Considerations

• The European Respiratory Society suggests considering antibiotics in patients aged >75 years with fever, cardiac failure, insulin-dependent diabetes, or serious neurological disorders, with a strength of evidence based on low-quality observational studies 21
• The European Society of Clinical Microbiology and Infectious Diseases recommends considering antibiotics in elderly or immunocompromised patients at high risk for complications, with a strength of evidence based on low-quality observational studies 22

Antibiotic Recommendations for High-Risk Patients with Acute Bronchitis

Defining High-Risk Patients and Antibiotic Use

• High-risk patients with significant comorbidities, such as cardiac failure, insulin-dependent diabetes, or immunosuppression, may require antibiotics, according to the Clinical Microbiology and Infection guideline 23

When to Prescribe Antibiotics

• The American Thoracic Society and Infectious Diseases Society of America recommend reserving antibiotics for high-risk patients who present with at least one key symptom, including increased dyspnea, increased sputum volume, or increased sputum purulence, as outlined in the Anthonisen criteria 24
• High-risk patients with acute bronchitis who meet the Anthonisen criteria may benefit from antibiotics, as suggested by the Clinical Microbiology and Infection guideline 23

Recommended Antibiotic Regimens

• The European Respiratory Society recommends doxycycline 100 mg twice daily for 7-10 days as a first-line option for moderate-severity exacerbations in high-risk patients, according to the Clinical Infectious Diseases journal 24 and the Clinical Microbiology and Infection guideline 23
• The British Thoracic Society suggests high-dose amoxicillin/clavulanate 625 mg three times daily for 14 days as a preferred option for severe exacerbations in high-risk patients, as recommended by the Thorax journal 25

Specific Pathogen Considerations

• For Haemophilus influenzae suspected or confirmed, the Infectious Diseases Society of America recommends amoxicillin 500 mg three times daily for 14 days for beta-lactamase negative strains, and amoxicillin/clavulanate 625 mg three times daily for 14 days for beta-lactamase positive strains, according to the Thorax journal 25
• For Moraxella catarrhalis suspected, the European Respiratory Society suggests amoxicillin/clavulanate 625 mg three times daily for 14 days, or clarithromycin 500 mg twice daily for 14 days, as recommended by the Thorax journal 25
• For Streptococcus pneumoniae suspected, the American Thoracic Society recommends amoxicillin 500 mg to 1 g three times daily for 14 days, or doxycycline 100 mg twice daily for 14 days, according to the Thorax journal 25

Duration of Therapy

• The standard duration of antibiotic therapy is 7-10 days for most cases, but may be extended to 14 days for patients with documented bacterial pathogens, as recommended by the Clinical Infectious Diseases journal 24 and the Clinical Microbiology and Infection guideline 23
• The Thorax journal suggests that 5 days of therapy may suffice for mild cases in patients with mild bronchiectasis or when using respiratory fluoroquinolones 25

Critical Pitfalls to Avoid

• Up to 25% of H. influenzae and 50-70% of M. catarrhalis produce β-lactamase, making simple aminopenicillins ineffective, according to the Clinical Infectious Diseases journal 24
• The Clinical Microbiology and Infection guideline recommends avoiding aminopenicillins alone, macrolides (older generation), first-generation cephalosporins, and cotrimoxazole due to increasing resistance 23
• The Thorax journal suggests obtaining sputum cultures when possible before starting empirical antibiotics, then adjusting therapy based on sensitivity results if no clinical improvement occurs 25

Amoxicillin Duration for Acute Bronchitis with Suspected Bacterial Infection

Introduction to Antibiotic Use

• The American Academy of Family Physicians recommends that antibiotics, including amoxicillin, should not be prescribed for uncomplicated acute bronchitis in otherwise healthy adults, as routine antibiotic treatment does not improve clinical outcomes regardless of cough duration 26, 27, 28

Indications for Antibiotic Use

• The American Academy of Family Physicians suggests that purulent sputum is present in 89-95% of viral bronchitis cases and does not indicate bacterial infection, and antibiotics provide no benefit 26, 27
• The European Society of Clinical Microbiology and Infectious Diseases recommends that if fever >38°C persists beyond 3 days, this strongly suggests bacterial superinfection rather than viral bronchitis and warrants treatment 29

Amoxicillin Duration and Dosing

• The European Society of Clinical Microbiology and Infectious Diseases recommends a duration of 5-8 days for amoxicillin treatment when bacterial infection is confirmed or strongly suspected (fever >3 days, high-risk patients) 29
• For adults with suspected bacterial bronchitis, the recommended dose is amoxicillin 500 mg three times daily for 5-8 days 29
• For children >3 months and <40 kg, the recommended dose is 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours for 5-8 days 29

Critical Clinical Considerations

• The American Academy of Family Physicians advises against assuming bacterial infection based on sputum color or purulence alone, duration of cough, or patient expectation for antibiotics 26, 27
• The American Academy of Family Physicians recommends always ruling out pneumonia first by checking vital signs and lung examination for focal findings, although no specific citation is provided for this fact, it is supported by 26

Special Populations

• The American Academy of Family Physicians suggests that these guidelines may not apply to elderly, immunocompromised, or patients with comorbidities (COPD, heart failure, diabetes), and a lower threshold for antibiotic use with longer duration (7-10 days) may be appropriate 26

Distinguishing Viral from Bacterial Bronchitis

Clinical Presentation

• Fever persisting beyond 3 days strongly suggests bacterial superinfection or pneumonia rather than viral bronchitis, which typically resolves within 7-10 days 30, 31, 32, 33
• The American Academy of Family Physicians suggests that cough typically lasts 10-14 days, with most symptoms resolving within 3 weeks 34, 35
• The presence of upper respiratory symptoms, such as rhinorrhea and nasal obstruction, suggests a viral etiology 30, 31, 32, 33
• Purulent sputum occurs in 89-95% of viral cases and does not indicate bacterial infection 34, 35

Treatment Guidelines

• The American College of Physicians recommends that antibiotics should not be prescribed immediately, even if fever is present, unless the patient has chronic obstructive bronchitis with respiratory insufficiency 30, 31, 32, 33, 35
• The Infectious Diseases Society of America suggests that antibiotics should be initiated if fever persists beyond 3 days or if the patient meets the Anthonisen criteria 30, 31, 32, 33
• The American Academy of Family Physicians recommends that symptomatic treatment and reassessment plan should be provided, and antibiotics should only be prescribed if necessary 30, 31, 32, 33, 35

Monitoring and Reevaluation

• The American College of Chest Physicians recommends that clinical reassessment should be performed 2-3 days after antibiotic initiation to evaluate treatment response 34, 35
• The patient should be reevaluated for other diagnoses, such as pneumonia or pertussis, if symptoms persist beyond 10-14 days 34, 35

Critical Pitfalls to Avoid

• The Centers for Disease Control and Prevention advises against using purulent sputum color or presence as an indication for antibiotics, as it occurs in 89-95% of viral cases 34, 35
• The American Academy of Family Physicians recommends against prescribing antibiotics for cough duration alone, as viral bronchitis cough lasts 10-14 days normally 34, 35
• The Infectious Diseases Society of America suggests that bacterial infection should not be assumed before the 3-day fever threshold, as most cases are viral 30, 31, 32, 33, 34, 35

Acute Viral Bronchitis Treatment

Symptomatic Treatment Recommendations

• The American College of Chest Physicians recommends that patients with acute viral bronchitis be informed that the cough typically lasts 10-14 days after consultation, even without antibiotics 36
• The American College of Chest Physicians suggests that the condition is self-limiting and resolves within 3 weeks 36
• Codeine or dextromethorphan can provide modest effects on the severity and duration of cough, especially when dry cough is bothersome and disturbs sleep 36
• If pertussis is confirmed or strongly suspected, a macrolide antibiotic (erythromycin or azithromycin) should be prescribed, and the patient should be isolated for 5 days from the start of treatment 36
• Early treatment (first weeks) decreases the paroxysms of cough and prevents the spread of the disease 36
• Reevaluation is necessary if the fever persists for more than 3 days, suggesting bacterial superinfection or pneumonia 36
• Reevaluation is also necessary if the cough persists for more than 3 weeks, considering other diagnoses such as asthma, COPD, or pertussis 36

Acute Bronchitis Management

Diagnosis and Assessment

• The American College of Chest Physicians recommends ruling out pneumonia, acute asthma, and exacerbation of Chronic Obstructive Pulmonary Disease (COPD) before diagnosing acute bronchitis 37, 38
• Acute bronchitis should not be diagnosed if the patient has a heart rate >100 beats per minute, respiratory rate >24 breaths per minute, oral temperature >38°C, or findings of focal consolidation on lung examination 37
• Approximately one-third of patients diagnosed with acute bronchitis actually have undiagnosed asthma 38, 39

Treatment

• The American College of Chest Physicians recommends against routine use of antibiotics for acute bronchitis, as they only reduce cough by about half a day while exposing the patient to adverse effects 37
• Antitussives (codeine or dextromethorphan) may provide modest short-term symptomatic relief, especially when dry cough is bothersome and disturbs sleep 37
• Bronchodilators (beta-2 agonists) should only be used in select adult patients with accompanying wheezing 37

Special Considerations

• Patients with COPD or underlying pulmonary disease are not included in standard recommendations for uncomplicated acute bronchitis 38, 39, 40
• For acute exacerbations of chronic bronchitis, consider antibiotics if the patient has at least one key symptom (increased dyspnea, sputum volume, or sputum purulence) and risk factors 38, 39, 40

Management Algorithm

• Evaluate vital signs and lung examination to rule out pneumonia 37
• Rule out asthma/COPD, especially if there are recurrent episodes 38, 39
• If uncomplicated acute bronchitis is confirmed, provide education on expected duration (2-3 weeks) and symptomatic treatment as needed 37
• Reevaluate if fever persists >3 days (consider bacterial superinfection or pneumonia) or cough persists >3 weeks (consider other diagnoses: asthma, COPD, pertussis, gastroesophageal reflux) 37, 38, 39, 40

Management of Acute Bronchitis

Guideline-Based Recommendations

• The American College of Chest Physicians recommends against routine prescription of medications, including montelukast, for acute bronchitis, as there is no evidence supporting their efficacy for this condition 41
• No routine medications, including antibiotics, antivirals, antitussives, inhaled beta-agonists, inhaled anticholinergics, inhaled corticosteroids, oral corticosteroids, or oral NSAIDs, should be prescribed for immunocompetent adult outpatients with acute bronchitis, unless they have been shown to be safe and effective at making cough less severe or resolve sooner 41

Evidence from Related Conditions

• The American College of Chest Physicians found that montelukast has not been evaluated specifically for acute bronchitis in adults or children, and its use is not supported by clinical trials 42, 41

What TO Do for Acute Bronchitis

• The American College of Chest Physicians recommends patient education and symptomatic treatment only, as the cornerstone of acute bronchitis management, with antitussives and beta-2 agonist bronchodilators considered only for bothersome symptoms 41, 42
• Patients should be advised to seek reassessment if fever persists beyond 3 days, cough persists beyond 3 weeks, or symptoms worsen rather than gradually improve 41

Acute Bronchitis Management

Initial Evaluation and Diagnosis

• The American College of Emergency Physicians recommends excluding pneumonia and other serious conditions before confirming acute bronchitis, with the primary goal of identifying key clinical indicators that suggest pneumonia rather than bronchitis 43, 44
• Chest radiography is indicated if any vital sign abnormalities or focal lung findings are present, or if cough persists ≥3 weeks without other known causes, according to the American College of Emergency Physicians 43, 44
• The American Thoracic Society suggests considering other diagnoses to exclude, such as common cold, asthma exacerbation, and COPD exacerbation, in patients with known conditions 45

Antibiotic Treatment

• The American College of Emergency Physicians recommends against routine antibiotic treatment for uncomplicated acute bronchitis in otherwise healthy adults, as they provide minimal benefit while exposing patients to adverse effects and contributing to antibiotic resistance 43, 44
• An exception to this recommendation is when pertussis is suspected or confirmed, in which case a macrolide antibiotic should be prescribed immediately, according to the American College of Emergency Physicians 43, 44

Patient Education and Follow-up

• The American College of Emergency Physicians suggests that patient satisfaction depends more on physician-patient communication than whether an antibiotic is prescribed, and that patients should be informed that cough typically lasts 10-14 days after the office visit, even without antibiotics 43, 44
• Patients should be instructed to return if fever persists >3 days, cough persists >3 weeks, or symptoms worsen rather than gradually improve, according to the American College of Emergency Physicians and the American Thoracic Society 43, 45

Antibiotic Use in Bronchitis

Patient Selection for Clarithromycin

• The European Respiratory Society recommends clarithromycin for acute bacterial exacerbation of chronic bronchitis (ABECB) in adults with confirmed chronic bronchitis or COPD, acute exacerbation with at least 2 of the Anthonisen criteria, and high-risk features such as age >65 years with moderate-to-severe COPD, cardiac failure, insulin-dependent diabetes, or serious neurological disorders 46

Dosing and Efficacy

• The American Thoracic Society suggests that clarithromycin extended-release 1000 mg once daily for 5-7 days achieves 90-97% clinical cure rates in ABECB, with a strength of evidence rated as high 46
• The Infectious Diseases Society of America recommends clarithromycin immediate-release 500 mg twice daily for 7-14 days as an alternative dosing regimen for ABECB, with a strength of evidence rated as moderate 46

Antibiotic Prescription Guidelines for Bronchitis

Introduction to Antibiotic Use in Bronchitis

• The American College of Physicians recommends that antibiotics should NOT be prescribed for acute uncomplicated bronchitis in otherwise healthy adults, regardless of cough duration or sputum color, as they provide minimal benefit while causing significant adverse effects 47

Acute Bronchitis Diagnosis and Treatment

• Before diagnosing acute bronchitis, it is essential to exclude pneumonia by checking for tachycardia, tachypnea, fever, and abnormal chest examination findings, and if any of these are present, consider pneumonia and obtain chest radiography rather than treating as simple bronchitis 47
• A systematic review of 15 randomized controlled trials found limited evidence supporting antibiotics and a trend toward increased adverse events in acute bronchitis patients 47
• One trial comparing amoxicillin-clavulanate to placebo showed no significant difference in days to cough resolution in acute bronchitis patients 47
• Macrolides, such as azithromycin, caused significantly more adverse events than placebo in acute bronchitis patients 47

Chronic Bronchitis Exacerbations

• For exacerbations of chronic obstructive bronchitis, prescribe antibiotics if the patient has chronic respiratory insufficiency, as indicated by dyspnea at rest and/or FEV1 <35% and hypoxemia at rest with PaO2 <60 mmHg 48, 49
• Delayed antibiotic indications include at least 2 of 3 Anthonisen criteria suggesting bacterial origin, such as increased volume of expectoration, increased purulence of expectoration, and increased dyspnea, as well as fever >38°C persisting for more than 3 days 48, 49, 50

Antibiotic Selection and Duration

• First-line antibiotics for infrequent exacerbations include amoxicillin, first-generation cephalosporins, and macrolides, such as azithromycin, or doxycycline for beta-lactam allergy 49
• Second-line antibiotics for frequent exacerbations or FEV1 <35% include amoxicillin-clavulanate, second-generation cephalosporins, third-generation cephalosporins, and respiratory fluoroquinolones, such as levofloxacin 49, 50
• The standard duration of treatment is 7-10 days 49, 50

Patient Management and Education

• Inform patients that cough typically lasts 10-14 days after the visit, even without antibiotics, and that the condition is self-limiting and resolves within 3 weeks 47
• Instruct patients to return if fever persists >3 days, cough persists >3 weeks, or symptoms worsen rather than gradually improve 47

Acute Viral Bronchitis Management

Introduction to Acute Viral Bronchitis

• The American College of Emergency Physicians and other medical societies recommend that azithromycin and all other antibiotics should not be prescribed for acute viral bronchitis in otherwise healthy adults, as they provide no clinical benefit while causing significant adverse effects 51, 52, 53

Etiology and Diagnosis

• Respiratory viruses cause 89-95% of acute bronchitis cases, making antibiotics completely ineffective regardless of which one you choose 51
• Purulent sputum does not indicate bacterial infection, as it occurs in 89-95% of viral bronchitis cases 51
• Cough duration does not indicate bacterial infection, with viral bronchitis cough typically lasting 10-14 days, sometimes up to 3 weeks 51, 53

Treatment and Management

• Fever persisting beyond 3 days strongly suggests bacterial superinfection or pneumonia rather than simple viral bronchitis and warrants reassessment, not immediate antibiotics 52
• Before diagnosing acute bronchitis, exclude pneumonia by checking for heart rate, respiratory rate, oral temperature, and abnormal chest examination findings, and obtain chest radiography if any of these are present 51, 53
• For confirmed or suspected pertussis, prescribe a macrolide antibiotic such as azithromycin immediately 53
• Inform patients that cough typically lasts 10-14 days after the visit and the condition is self-limiting, resolving within 3 weeks 53
• Consider symptomatic relief with codeine or dextromethorphan for bothersome dry cough, and use β2-agonist bronchodilators only in select patients with accompanying wheezing 53

Patient Education and Communication

• Explain to patients that antibiotics expose them to adverse effects while contributing to antibiotic resistance without providing benefit 53

Management of Acute Bronchitis

Primary Treatment: Symptomatic Management and Patient Education

• The American Academy of Emergency Medicine recommends informing patients that cough typically lasts 10-14 days after the visit, even without antibiotics, and may persist up to 3 weeks 54
• Patient satisfaction depends more on physician-patient communication than whether an antibiotic is prescribed, according to the American Academy of Emergency Medicine 54
• Personalizing the risks of unnecessary antibiotic use, such as previous antibiotic use increasing carriage of resistant bacteria, is recommended by the American Academy of Emergency Medicine 54
• β2-agonist bronchodilators, such as albuterol, may be useful only in select adult patients with wheezing accompanying the cough, as evidenced by the American Academy of Emergency Medicine 54
• Antitussives, such as codeine or dextromethorphan, may provide modest effects on severity and duration of cough, particularly when dry cough is bothersome and disturbs sleep, according to the American Academy of Emergency Medicine 54
• Elimination of environmental cough triggers and vaporized air treatments are recommended as low-risk measures by the American Academy of Emergency Medicine 54

Management of Acute Exacerbations of Chronic Bronchitis

• The American College of Chest Physicians recommends antibiotics for acute exacerbations of chronic bronchitis, particularly in patients with severe exacerbations, those with more severe airflow obstruction at baseline, and patients with purulent sputum and cardinal symptoms 55, 56
• Short-acting β-agonists improve pulmonary function, breathlessness, and exercise tolerance, according to the American College of Chest Physicians 56
• Ipratropium bromide reduces cough frequency and severity, and decreases sputum volume, as recommended by the American College of Chest Physicians 56
• Smoking cessation is the most effective intervention for chronic bronchitis, with 90% of patients experiencing resolution of chronic cough after quitting, according to the American College of Chest Physicians 55

Post-Viral Bronchitis Medical Management

Initial Assessment and Diagnosis

• The American College of Emergency Physicians recommends excluding pneumonia by evaluating for heart rate >100 beats/min, respiratory rate >24 breaths/min, and oral temperature >38°C in patients with suspected post-viral bronchitis 57

Primary Management: Symptomatic Treatment Only

• The American Academy of Emergency Medicine suggests that respiratory viruses cause 89-95% of acute bronchitis cases, and antibiotics provide no clinical benefit while exposing patients to adverse effects and contributing to antibiotic resistance 58
• Nasal saline irrigation may be a useful low-risk supportive measure for patients with post-viral bronchitis 57

Special Populations Requiring Different Approach

• Patients with certain conditions, such as COPD or chronic bronchitis, immunocompromised state, cardiac failure, may require antibiotics and are beyond the scope of uncomplicated post-viral bronchitis 57

Antibiotics for Outpatient Bronchitis

Initial Assessment and Diagnosis

• The American College of Chest Physicians recommends checking vital signs immediately, as heart rate >100 bpm, respiratory rate >24 breaths/min, or oral temperature >38°C suggests pneumonia, not bronchitis 59
• Approximately one-third of patients diagnosed with "recurrent acute bronchitis" actually have undiagnosed asthma or COPD exacerbations 59

The Evidence Against Antibiotics in Acute Bronchitis

• The 2020 CHEST Expert Panel found that antibiotics reduce cough duration by only 0.5 days (approximately 12 hours) 60
• The 2020 CHEST Expert Panel also found that antibiotics significantly increase adverse events (RR 1.20; 95% CI 1.05-1.36) 60
• There is no difference in clinical outcomes between antibiotic and placebo groups 60, 61, 59

Appropriate Management

• The American College of Chest Physicians recommends against routine use of antibiotics, antiviral therapy, inhaled corticosteroids, oral corticosteroids, oral NSAIDs at anti-inflammatory doses, and expectorants or mucolytics 60, 61, 59, 62
• The American College of Chest Physicians recommends providing education on expected 10-14 day duration and offering symptomatic treatment (antitussives if bothersome dry cough) 60, 61
• The American College of Chest Physicians recommends reassessing if fever >3 days or cough >3 weeks 60, 61

Special Populations

• The American College of Chest Physicians recommends considering antibiotics more readily in elderly patients with comorbidities (cardiac failure, insulin-dependent diabetes) 60, 61

Doxycycline for Acute Bronchitis: Not Recommended

The Evidence Against Doxycycline

• The American College of Emergency Physicians recommends against routine antibiotic treatment of uncomplicated acute bronchitis, regardless of duration of cough, presence of purulent sputum, or patient expectations 63, 64
• A 1976 randomized controlled trial showed no significant differences between doxycycline and placebo for average days of daytime cough, purulent sputum, feeling unwell, or days of missed work 63, 64, 65
• The American College of Emergency Physicians found that doxycycline did not improve outcomes, including duration of cough, clinical improvement at one week, days away from work, and subjective ratings of cough severity 63, 65

Why Antibiotics Don't Work

• Respiratory viruses cause 89-95% of acute bronchitis cases, according to the American College of Emergency Physicians 64
• Only 5-10% of cases involve bacterial pathogens, such as Bordetella pertussis, Mycoplasma pneumoniae, and Chlamydophila pneumoniae 64
• Common encapsulated bacteria like Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis do not cause acute bronchitis in adults without underlying lung disease, as stated by the American College of Emergency Physicians 64, 66
• The FDA removed uncomplicated acute bronchitis as an indication for antimicrobial therapy in 1998, as reported by the American College of Emergency Physicians 64, 65

Guideline on the Use of Clarithromycin in Acute Bronchitis, Asthma, and Chronic Bronchitis Exacerbations

1. Acute Bronchitis – Antibiotic Use Not Recommended

• Routine antibiotic therapy, including clarithromycin, provides no clinical benefit for uncomplicated acute bronchitis regardless of cough duration, sputum color, or patient expectations. [American College of Emergency Medicine] 67
• Respiratory viruses are responsible for approximately 89 %–95 % of acute bronchitis episodes, rendering antibiotics ineffective against the underlying cause. [American Family Physician] 68
• The presence of purulent sputum occurs in 89 %–95 % of viral cases and does not indicate a bacterial infection that warrants antibiotics. [American Family Physician] 68

2. Pertussis Exception

• When pertussis (whooping cough) is confirmed or strongly suspected, a macrolide such as azithromycin or erythromycin should be prescribed promptly. [American Family Physician] 68

3. Patient Education for Uncomplicated Acute Bronchitis

• Patients should be informed that cough typically persists 10–14 days after the clinical encounter and may last up to 3 weeks, even without antibiotic therapy. [American Family Physician] 68

4. Reactive Airway Disease (Asthma) – Diagnostic Pitfalls and Management

• Cough‑variant asthma should be considered in adults with a persistent cough lasting >2–3 weeks that worsens at night or after exposure to cold or exercise. [American College of Emergency Medicine] 67
• Diagnosis is supported by symptom improvement after bronchodilator use or a positive methacholine challenge test. [American College of Emergency Medicine] 67

5. Contraindications for Clarithromycin

• Do not prescribe clarithromycin for uncomplicated acute bronchitis in otherwise healthy adults. [American College of Emergency Medicine; American Family Physician] [67][68]
• Do not prescribe clarithromycin based solely on the presence of purulent sputum. [American Family Physician] 68
• Do not use clarithromycin for asthma or reactive airway disease. [American College of Emergency Medicine] 67
• Do not prescribe clarithromycin for simple viral upper‑respiratory infections. [American Family Physician] 68

6. Diagnostic Evaluation Before Labeling Acute Bronchitis

• Perform a focused chest examination for focal findings that would suggest pneumonia; such findings should prompt reconsideration of the diagnosis. [American College of Emergency Medicine] 67

7. Education on Expected Illness Course for Acute Bronchitis

• Reinforce to patients that the expected duration of cough in uncomplicated acute bronchitis is 10–14 days, with guidance to seek further care if fever persists >3 days or cough exceeds 3 weeks. [American Family Physician] 68

Management of Uncomplicated Acute Bronchitis in Healthy Adults

Epidemiology & Etiology

• Respiratory viruses are responsible for 89–95 % of acute bronchitis episodes in adults, leaving only 5–10 % attributable to atypical bacteria such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, or Bordetella pertussis【69】【70】.
• Typical encapsulated bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) do not cause acute bronchitis in adults without pre‑existing lung disease【69】.

Diagnostic Pitfalls

• Purulent (green/yellow) sputum occurs in 89–95 % of viral bronchitis and does not indicate bacterial infection; it reflects inflammatory cells rather than pathogens【70】.
• Cough duration is not a marker of bacterial infection – viral bronchitis cough usually lasts 10–14 days and may persist up to 3 weeks【71】【70】.

Excluding Pneumonia

• In adults < 70 years without comorbidities, the likelihood of pneumonia is low if all of the following are absent: heart rate > 100 bpm, respiratory rate > 24 breaths/min, temperature > 38 °C, and abnormal chest examination (rales, egophony, tactile fremitus)【70】.
• Presence of any of these findings should prompt chest radiography rather than a presumptive bronchitis diagnosis【70】.

Evidence Against Routine Antibiotics

• Antibiotic therapy shortens cough by ≈0.5 day (≈12 hours) but increases adverse events (risk ratio 1.20; 95 % CI 1.05–1.36)【70】 – evidence from meta‑analysis of randomized trials (moderate certainty).
• A randomized trial comparing amoxicillin‑clavulanate with placebo found no significant difference in time to cough resolution【70】.
• The FDA removed uncomplicated acute bronchitis from the list of approved antimicrobial indications in 1998 due to lack of efficacy【69】.

Exception – Pertussis

• When pertussis is confirmed or strongly suspected, prescribe a macrolide (azithromycin or erythromycin) promptly; cephalosporins such as Omnicef are ineffective【70】.

Patient Communication & Symptomatic Care

• Counsel patients that cough typically persists 10–14 days after the visit and may last up to 3 weeks even without antibiotics【71】【70】.
• Physician‑patient communication has a greater impact on patient satisfaction than the prescription of antibiotics【71】.
• Recommended symptomatic measures (supported by evidence) include:
  
  • Antitussives (e.g., codeine or dextromethorphan) for bothersome dry cough, especially at night【70】.
  • Short‑acting β₂‑agonists (e.g., albuterol) only for patients with concurrent wheezing【70】.
  • Removal of environmental cough triggers and use of humidified air【70】.

Scope of the Recommendations

• These recommendations apply exclusively to otherwise healthy adults without underlying lung disease; patients with COPD, chronic bronchitis, heart failure, immunosuppression, or age > 75 years with comorbidities may require a different approach【71】【70】.

Management of Acute Uncomplicated Bronchitis in Otherwise Healthy Adults

Antibiotic Stewardship

• Routine antibiotics are not recommended for acute uncomplicated bronchitis in otherwise healthy adults because the illness is viral in ≈ 90 % of cases, antibiotics shorten cough by only ≈ 0.5 day and increase adverse events (RR 1.20; 95 % CI 1.05‑1.36) while fostering resistance. 72

Diagnostic Approach – Excluding Pneumonia

• In adults < 70 years without comorbidities, if all four** of the following are absent—heart rate > 100 bpm, respiratory rate > 24 breaths/min, temperature > 38 °C, and abnormal chest exam—pneumonia is unlikely and a chest X‑ray is not required**. 72
• The presence of any one of those findings warrants a chest radiograph to rule out pneumonia before treating as bronchitis. 72

Etiology & Clinical Indicators

• Respiratory viruses account for 89‑95 % of acute bronchitis episodes; therefore, antibiotics cannot target the underlying cause. 72
• Purulent (green/yellow) sputum occurs in 89‑95 % of viral cases and does not indicate bacterial infection; it reflects inflammatory cells rather than bacteria. 72

Evidence Summary (Meta‑analysis)

These data support the recommendation against routine antibiotic use. 72

Pertussis Exception

• When pertussis is confirmed or strongly suspected, prescribe a macrolide (azithromycin or erythromycin) promptly and isolate the patient for 5 days from treatment start; early therapy reduces coughing paroxysms and limits transmission. 72

Symptomatic Management

Recommended Measures

• Antitussives (codeine or dextromethorphan) for bothersome dry cough, especially if it disrupts sleep—provides modest relief. 72
• Short‑acting β₂‑agonists (e.g., albuterol) only for patients who have wheezing accompanying the cough. 72
• Environmental measures: remove cough triggers and use humidified air. 72

Not Recommended

• Routine use of expectorants, mucolytics, antihistamines, inhaled or oral corticosteroids, or NSAIDs at anti‑inflammatory doses—no consistent benefit demonstrated. 72

Patient Communication & Expectations

• Physician‑patient communication has a greater impact on patient satisfaction than whether an antibiotic is prescribed. 72
• Counsel that cough typically lasts 10‑14 days and may persist up to 3 weeks even without antibiotics. 72
• Emphasize that antibiotics expose patients to adverse effects (e.g., diarrhea, rash, yeast infection) and promote resistance without meaningful clinical benefit. 72
• Referring to the illness as a “chest cold” rather than “bronchitis” can lower expectations for antibiotics. 72

High‑Risk Populations (Outside Scope of This Guideline)

• Patients with chronic lung disease (e.g., COPD, chronic bronchitis, bronchiectasis, cystic fibrosis) or immunosuppression may require antibiotics; these groups are not covered by the uncomplicated‑bronchitis recommendations. 72

Common Pitfalls to Avoid

• Do not prescribe antibiotics based on purulent sputum color—this finding occurs in the majority of viral cases. 72
• Do not rely on cough duration alone to justify antibiotics; viral cough normally lasts 10‑14 days. 72
• Do not assume early fever (first 1‑3 days) indicates bacterial infection; only fever persisting > 3 days suggests possible bacterial superinfection. 72

Management of Acute Bronchitis: Evidence‑Based Recommendations

Natural History & Patient Expectations

• Cough associated with acute bronchitis usually lasts 10–14 days and can persist up to 3 weeks even without antibiotic therapy. (Annals of Emergency Medicine 2001) 73
• Patient satisfaction is driven more by clear physician‑patient communication than by receipt of antibiotics. (Annals of Emergency Medicine 2001) 73
• Prescribing antibiotics solely to meet patient expectations does not improve outcomes and should be avoided; focus on communication instead. (Annals of Emergency Medicine 2001) 73
• Referring to the illness as a “chest cold” rather than “bronchitis” reduces the patient’s demand for antibiotics. (Annals of Emergency Medicine 2001) 73

Symptomatic Management

• Dextromethorphan or codeine provide modest relief for bothersome dry cough. (Annals of Emergency Medicine 2001) 73
• Short‑acting β₂‑agonists (e.g., albuterol) should be used only when wheezing accompanies the cough. (Annals of Emergency Medicine 2001) 73
• Environmental control (removing dust, dander, and other irritants) is a low‑risk supportive measure to lessen cough severity. (Annals of Emergency Medicine 2001) 73
• Humidified air, especially in low‑humidity settings, can help alleviate cough symptoms. (Annals of Emergency Medicine 2001) 73

Communication Strategy

• An effective communication plan includes:

Management of Recurrent Acute Bronchitis in Otherwise Healthy Adults

Diagnosis and Exclusion of Alternative Causes

• Perform spirometry or peak‑flow testing in patients who smoke or have risk factors to identify undiagnosed asthma or COPD, using ≥12 % and ≥200 mL FEV₁ improvement after bronchodilator (or ≥20 % peak‑flow improvement) as diagnostic thresholds. 74
• Assess vital signs and lung examination before labeling an episode as bronchitis; heart rate > 100 bpm, respiratory rate > 24 breaths/min, temperature > 38 °C, or abnormal chest findings (rales, egophony, increased tactile fremitus) should prompt chest radiography to rule out pneumonia. 75

Evidence Against Routine Antibiotic Use

• Respiratory viruses are responsible for 89–95 % of acute bronchitis cases, rendering antibiotics ineffective regardless of the agent chosen. Strength: high‑quality epidemiologic data. 75
• Antibiotics shorten cough duration by ≈0.5 days (≈12 hours) but increase adverse events (risk ratio 1.20; 95 % CI 1.05–1.36). Strength: moderate‑quality randomized trials. 75
• Purulent (green/yellow) sputum occurs in 89–95 % of viral bronchitis and does not indicate bacterial infection. Strength: observational data. 75
• Cough duration is not a reliable marker of bacterial infection; viral cough typically lasts 10–14 days and may persist up to 3 weeks. Strength: clinical cohort data. 75

Recommendations on Other Pharmacologic Therapies

• The 2020 CHEST Expert Panel recommends against routine prescription of:
  
  • Antiviral agents (unless influenza is confirmed within 48 h of symptom onset).
  • Inhaled β₂‑agonists (except in patients with documented wheezing).
  • Inhaled anticholinergics.
  • Inhaled or oral corticosteroids.
  • Oral NSAIDs at anti‑inflammatory doses.
  • Expectorants or mucolytics.
    Strength: expert consensus (GRADE: weak recommendation, low‑certainty evidence). [75][74]

Patient Education and Symptomatic Relief

• Counsel patients that cough usually resolves in 10–14 days and may last up to 3 weeks without treatment; emphasize that antibiotics do not shorten the illness and expose patients to side‑effects (diarrhea, rash, candidiasis) and antimicrobial resistance. Strength: expert consensus. 75
• Offer modest symptomatic relief for bothersome dry cough (especially nocturnal) with codeine or dextromethorphan. Strength: low‑quality evidence. 75
• Reserve short‑acting β₂‑agonists (e.g., albuterol) for patients who demonstrate wheezing accompanying the cough. Strength: expert consensus. 75
• Recommend environmental measures—removal of irritants (dust, dander) and use of humidified air—to reduce cough severity. Strength: expert consensus. 75

Pertussis Exception

• If pertussis is confirmed or strongly suspected (paroxysmal cough, post‑tussive vomiting, inspiratory “whoop,” cough > 2 weeks), prescribe a macrolide antibiotic (azithromycin or erythromycin) immediately and isolate the patient for 5 days from treatment start; early therapy reduces cough paroxysms and limits transmission. Strength: moderate‑quality evidence. 75

When to Reassess (Red‑Flag Criteria)

• Advise return if fever persists > 3 days, suggesting possible bacterial superinfection or pneumonia. 75
• Advise return if cough persists > 3 weeks, prompting evaluation for asthma, COPD, pertussis, gastro‑esophageal reflux, or upper‑airway cough syndrome. 75
• Advise return if symptoms worsen rather than gradually improve. 75

Special Populations (Outside Scope of This Guideline)

• The above recommendations apply only to otherwise healthy adults. Patients with COPD or chronic bronchitis, heart failure, immunosuppression, or age > 75 years with significant comorbidities require individualized management. Strength: expert consensus. [75][74]